This company has been acquired
Resumen de acción VILG.F
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Yourgene Health Plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.003 |
| 52 Week High | UK£0.07 |
| 52 Week Low | UK£0.0005 |
| Beta | 0.86 |
| 1 Month Change | 0% |
| 3 Month Change | 500.00% |
| 1 Year Change | n/a |
| 3 Year Change | -98.57% |
| 5 Year Change | n/a |
| Change since IPO | -97.00% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| VILG.F | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0% | -1.2% | -0.2% |
| 1Y | n/a | 5.5% | 25.6% |
Rentabilidad vs. Industria: Insufficient data to determine how VILG.F performed against the US Medical Equipment industry.
Rentabilidad vs. Mercado: Insufficient data to determine how VILG.F performed against the US Market.
Volatilidad de los precios
| VILG.F volatility | |
|---|---|
| VILG.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Precio estable de las acciones: VILG.F's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine VILG.F's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 253 | Lyn Rees | www.yourgene-health.com |
Resumen de fundamentos de Yourgene Health Plc
| Estadísticas fundamentales de VILG.F | |
|---|---|
| Capitalización bursátil | US$20.69m |
| Beneficios(TTM) | -US$10.28m |
| Ingresos (TTM) | US$37.33m |
0.6x
Ratio precio-ventas (PS)-2.0x
Ratio precio-beneficio (PE)¿Está VILG.F sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de VILG.F | |
|---|---|
| Ingresos | UK£29.67m |
| Coste de los ingresos | UK£13.21m |
| Beneficio bruto | UK£16.46m |
| Otros gastos | UK£24.63m |
| Beneficios | -UK£8.17m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.0026 |
| Margen bruto | 55.48% |
| Margen de beneficio neto | -27.55% |
| Ratio deuda/patrimonio | 15.7% |
¿Cómo se ha desempeñado VILG.F a largo plazo?
Ver rendimiento histórico y comparativa